A randomized, open, two-agent, single-dose postprandial bioequivalence trial of arbidol hydrochloride tablets in healthy subjects

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 1527891f8a48656d4cf156366da47465b624655c
First added on: Jan 17, 2026